Liberty Global Ltd Class C vs Nuwellis Inc — how do they compare? Liberty Global Ltd Class C trades at $9.98 (market cap $3.48B), while Nuwellis Inc trades at $1.5 (market cap $522.76K). The key difference: Liberty Global Ltd Class C is far larger — about 6657× Nuwellis Inc's market cap, and Liberty Global Ltd Class C is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| LBTYK | NUWE | |
|---|---|---|
Market Cap | $3.48B | $522.76K |
Sector | Technology | Technology |
52-Week High | $12.67 | $220.50 |
52-Week Low | $9.59 | $1.42 |
Enterprise Value | $10.13B | -$1.29M |
Signals from Pluang's Aura AI — not financial advice
LBTYK trades at $10.24, down 2.38% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $7.14 billion in 2025, though operating cash flow remains positive at $1.21 billion. Recent news highlights the completion of the VodafoneZiggo buyout and preparations for a 2027 Ziggo Group listing, a key strategic move.
Despite deep losses, the stock appears undervalued on price-to-sales (0.7) and price-to-book (0.37) metrics. Analyst sentiment is strongly bullish (69% buy ratings), seeing upside from asset monetization and the Ziggo spin-off. Key risks include persistent negative margins and execution of the separation plan.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →